| Name | Title | Contact Details |
|---|
DANTOM provides flexible and professional credit and collection letter formats (fonts, color, logos, digitized signatures, variable address blocks, state conditionals for FDCPA compliance, state block.
Skarshaug Testing is a Ames, IA-based company in the Business Services sector.
We provide Instant Equipment Financing Quotes from Leading Finance Companies. LeaseQ is the fastest and safest way to get competitive equipment financing quotes from leading finance companies and submit a pre-qualified application with the finance company you choose... all in less than 2 minutes. No sales reps. You`re in control. Fast, Easy, Free! LeaseQ`s free proprietary comparison shopping and lease rating platform is a cloud based SaaS solution that enables: 1) Businesses looking for equipment financing to find the best leasing plans and rates in less than two minutes; 2) Dealers to get rates instantly so they can close sales while a prospect is still in the dealership; and 3) Leasing Companies to generate instant quotes and cost effective qualified leads.
At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN
We are a leading provider of tailored marketing and loyalty solutions worldwide.